Dr. Hoth is a consultant to the pharmaceutical and biotech industry in the areas of drug development and clinical trials. He is a medical oncologist with more than twenty-five years experience in clinical development of investigational drugs. Most recently he served as Senior Vice President of Development, and Chief Medical Officer of Axys Pharmaceuticals. Prior to that, he was at Cell Genesys as Senior Vice President and Chief Medical Officer from 1993 to 1997. From 1987 to 1993 he was Director, Division of AIDS at the National Institute of Allergy and Infectious Disease, and from 1980 to 1987 at the National Cancer Institute as Chief, Investigational Drug Branch, responsible for all clinical investigations of IND stage anti-cancer pharmaceuticals. Before NCI, Dr. Hoth was on the faculty of the Georgetown University School of Medicine. He currently serves on several clinical and scientific advisory Boards, and the Board of Directors of Acologix, Inc., a privately held biotech firm, where he also serves as Chairman of the Governance and Nominating Committee. Dr. Hoth has participated in four NDAs and has experience developing small molecules, antibodies, cytokines, gene therapy, and vaccines. He has also served as a consultant to both FDA and NIH in oncology drug development. Dr. Hoth received his M.D. from Georgetown University School of Medicine and AB in Psychology from Franklin and Marshall College.